NCT01062893

Brief Summary

An attempt is being made to see if by injecting a set volume of sterile saline into the epidural space during the treatment of labor pain with a combined spinal/epidural (CSE) increases the amount of pain relief obtained and makes the labor analgesia lasts longer. Subjects are in the study from the time their CSE is placed until they request additional pain medication from the spinal dose of numbing medicine wearing off.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
82

participants targeted

Target at P50-P75 for phase_2

Timeline
Completed

Started Aug 2009

Typical duration for phase_2

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2009

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

February 1, 2010

Completed
3 days until next milestone

First Posted

Study publicly available on registry

February 4, 2010

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2012

Completed
6.1 years until next milestone

Results Posted

Study results publicly available

October 16, 2018

Completed
Last Updated

October 16, 2018

Status Verified

October 1, 2018

Enrollment Period

3.1 years

First QC Date

February 1, 2010

Results QC Date

September 10, 2018

Last Update Submit

October 12, 2018

Conditions

Keywords

labor pain treatmentduration analgesiaAnalgesic duration with normal saline injection.Analgesic duration without normal saline injection

Outcome Measures

Primary Outcomes (1)

  • Highest Sensory Blockade Level to Pinprick and to Cold

    Onset of analgesia to recession of analgesia. Highest spread of analgesia (highest sensory level) to cold temp and pinprick, with level defined from T1 to L5, where T1 is highest =level 17 and L5 is lowest =Level 1)

    up to 20 minutes

Secondary Outcomes (10)

  • Duration of Analgesia (Time to Request Additional Analgesia)

    up 120 minutes

  • Onset of Analgesia

    up to 20 minutes

  • Time to Highest Sensory Block

    up to 20 minutes

  • Number of Participants Who Had Occurrence of Fetal Bradycardia

    length of labor, up to 24 hours

  • Number of Participants Who Had Occurrence of Maternal Hypotension

    length of labor, up to 24 hours

  • +5 more secondary outcomes

Study Arms (2)

0 mls saline injected

PLACEBO COMPARATOR

NO SALINE INJECTED

Other: Sterile normal saline 0 mls

15 mls saline

ACTIVE COMPARATOR

15ML SALINE ADMINISTERED EPIDURALLY

Other: 15 mls sterile normal saline

Interventions

at time of epidural needle placement there will not be any saline injected into the epidural space prior to placement of the spinal needle to administer the CSE dose of standard analgesic medications. Instead a pause will be done as by the investigator to maintain blind for the assessor.

0 mls saline injected

After the epidural needle is placed, 15 mls of sterile normal saline will be injected into the epidural space, then the spinal needle will be placed to administer the CSE dose of standard analgesic medications.

15 mls saline

Eligibility Criteria

Age12 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • age greater than 12 years of age
  • ASA status 1 or 2
  • cervical dilation \< 6cm

You may not qualify if:

  • ASA assigned 3 or 4
  • advanced labor (\> 6cm cervical dilated)
  • distorted epidural anatomy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Forsyth Medical Center-Sara Lee Center for Women's Health

Winston-Salem, North Carolina, 27103, United States

Location

MeSH Terms

Conditions

Labor Pain

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
Peter H. Pan, MD
Organization
Wake Forest University School of Medicine

Study Officials

  • Peter H Pan, MD, MSEE

    Wake Forest University Health Sciences

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 1, 2010

First Posted

February 4, 2010

Study Start

August 1, 2009

Primary Completion

September 1, 2012

Study Completion

September 1, 2012

Last Updated

October 16, 2018

Results First Posted

October 16, 2018

Record last verified: 2018-10

Locations